Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • 035 Continuation study

    An open-label treatment-option protocol of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma systemic anaplastic large cell lymphoma or CD30-positive cutaneous T-cell lymphoma

    View Trial
  • NMR metabolomics on exhaled breath condensate as a biomarker of lung involvement in rheumatoid arthritis

    View Trial
  • IMPOWER

    GO40241: A PHASE III DOUBLE-BLINDED MULTICENTER RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT TREATMENT WITH ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE II IIIA OR SELECT IIIB NON-SMALL CELL LUNG CANCER

    View Trial
  • MARS 2

    Mesothelioma and Radical Surgery 2: a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma

    View Trial
  • Person Centred Planning for Children Young People and Families with life limiting or life threatening illness: A scoping exercise exploring its use in practice within three care settings

    View Trial
  • Lung MATRIX

    Multi-drug genetic marker-directed non-comparative multi-arm Phase II trial in Non-Small Cell Lung Cancer

    View Trial
  • A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

    View Trial
  • Safety and Tolerability of AGI-134

    A phase I/IIa multicentre open label study designed to evaluate the safety and tolerability of AGI-134 as monotherapy and in combination with pembrolizumab in unresectable metastatic solid tumours

    View Trial
  • MERU

    A Randomized Double-Blind Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)

    View Trial
  • AdipO2 study

    Body fat distribution and diabetes risk: the role of adipose tissue oxygen metabolism

    View Trial